Crescent Sterling’s Schwab US Dividend Equity ETF SCHD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.82M Buy
277,997
+8,026
+3% +$255K 7.89% 1
2026
Q1
$8.28M Buy
269,971
+6,573
+2% +$199K 8.01% 1
2025
Q4
$7.23M Buy
263,398
+12,639
+5% +$344K 7.41% 1
2025
Q3
$6.85M Buy
250,759
+9,371
+4% +$256K 7.2% 1
2025
Q2
$6.4M Sell
241,388
-2,770
-1% -$72.3K 7.16% 1
2025
Q1
$6.83M Buy
244,158
+13,954
+6% +$389K 7% 1
2024
Q4
$6.29M Buy
230,204
+13,334
+6% +$379K 6.45% 1
2024
Q3
$6.11M Sell
216,870
-4,224
-2% -$115K 5.82% 1
2024
Q2
$5.73M Buy
221,094
+4,077
+2% +$106K 5.49% 1
2024
Q1
$5.83M Buy
217,017
+5,190
+2% +$134K 5.32% 1
2023
Q4
$5.38M Buy
211,827
+3,009
+1% +$71.7K 5.36% 1
2023
Q3
$4.93M Sell
208,818
-9,306
-4% -$228K 5.21% 1
2023
Q2
$5.28M Buy
218,124
+9,312
+4% +$222K 5.01% 2
2023
Q1
$5.09M Buy
208,812
+21,321
+11% +$533K 4.95% 2
2022
Q4
$4.72M Buy
+187,491
New +$4.63M 5.07% 3

Other funds holding SCHD

Crescent Sterling's SCHD Position: Q2 2026 in Review

Crescent Sterling increased its Schwab US Dividend Equity ETF (SCHD) stake by 3% in Q2 2026, buying an estimated $255K and bringing the position to 277,997 shares worth $8.82M. The position accounts for 7.89% of the portfolio, ranked #1.

Crescent Sterling first reported a position in SCHD in Q4 2022 and has held it in 15 quarters since. 621 funds tracked by Wall St. Rank hold SCHD as of Q2 2026.

  • Crescent Sterling held 277,997 shares of Schwab US Dividend Equity ETF worth $8.82M as of Q2 2026.
  • Crescent Sterling bought 8,026 Schwab US Dividend Equity ETF shares in Q2 2026, an estimated $255K.
  • Schwab US Dividend Equity ETF made up 7.89% of Crescent Sterling's portfolio in Q2 2026, its #1 holding.
  • Crescent Sterling first reported a position in Schwab US Dividend Equity ETF in Q4 2022 and has held it in 15 quarters since.
  • 621 funds tracked by Wall St. Rank held Schwab US Dividend Equity ETF as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.